Cognitive-affective manifestations since premanifest phases of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease

被引:1
|
作者
Bolzan, Gabriela [1 ,2 ]
Eyng, Maria E. Mueller [3 ]
Leotti, Vanessa B. [4 ,5 ]
Saraiva-Pereira, Maria L. [1 ,6 ,7 ]
Jardim, Laura B. [1 ,6 ,8 ,9 ]
机构
[1] Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, Brazil
[2] Hosp Clin Porto Alegre, Ctr Pesquisa Clin & Expt, Porto Alegre, Brazil
[3] Univ Fed Rio Grande do Sul, Fac Med, Porto Alegre, Brazil
[4] Univ Fed Rio Grande do Sul, Dept Estat, Porto Alegre, Brazil
[5] Univ Fed Rio Grande do Sul, Programa Posgrad Epidemiol, Porto Alegre, Brazil
[6] Hosp Clin Porto Alegre, Serv Genet Med, Rua Ramiro Barcelos 2350, BR-90035003 Porto Alegre, Brazil
[7] Univ Fed Rio Grande do Sul, Dept Bioquim, Porto Alegre, Brazil
[8] Univ Fed Rio Grande do Sul, Dept Med Interna, Porto Alegre, Brazil
[9] Hosp Clin Porto Alegre, DMI FAMED UFRGS, Rua Ramiro Barcelos 2350, BR-90035003 Porto Alegre, Brazil
关键词
Cerebellar Cognitive Affective; Schmahmann Syndrome; Spinocerebellar Ataxia Type 3; Machado-Joseph Disease; Cognition; Affect; MACHADO-JOSEPH-DISEASE; NEUROPATHOLOGY; DYSFUNCTION; SCALE; MIND;
D O I
10.1016/j.cortex.2023.09.021
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Background: Cognitive deficits were related to Spinocerebellar Ataxia type 3/MachadoJoseph Disease (SCA3/MJD), but the Cerebellar Cognitive Affective Syndrome (CCAS) needs further investigation in this disorder. We aimed to characterize cognitive-affective deficits in manifest and premanifest SCA3/MJD carriers.Methods: Subjects at 50% risk, manifest carriers and unrelated controls were evaluated inperson or in virtual settings with CCAS Scale (CCAS-S), Stroop Color-Word Test (SCWT), Trail-Making Test (TMT), and Reading the Mind in the Eyes Test (RMET). Scale for Assessment and Rating of Ataxia (SARA) >2.5 or Friedreich Ataxia Rating Scale/Activities of Daily Living (FARS-adl) >4 divided carriers into manifest and premanifest. Time after onset or time left to gait ataxia onset (TimeToAfterOnset) were estimated. Differences between groups and correlations with TimeToAfterOnset, SARA and FARS-adl were checked.Results: After random selection to balance groups, 23 manifest and 35 premanifest carriers, and 58 controls were included. CCAS-S, semantic fluency, phonemic fluency, category switching, affect, SCWT, and RMET showed significant differences between manifest carriers and controls; premanifest carriers mostly displayed intermediate values between controls and manifest carriers. These variables correlated with TimeToAfterOnset and SARA scores of the carriers. Correlations with SARA were stronger in the pre-ataxic group. CCAS-S had the strongest correlations with time and SARA. Discussion: Cognitive-affective deficits in SCA3/MJD involve executive function, language, affect, and social cognition, which seem to be altered prior to the ataxia onset, and correlate with markers of motor progression. CCAS-S was the most promising biomarker and should be evaluated in longitudinal studies.(c) 2023 Elsevier Ltd. All rights reserved.
引用
收藏
页码:370 / 382
页数:13
相关论文
共 50 条
  • [21] Identification of a potential exosomal biomarker in spinocerebellar ataxia Type 3/Machado-Joseph disease
    Hou, Xiaocan
    Gong, Xuan
    Zhang, Longbo
    Li, Tianjiao
    Yuan, Hongyu
    Xie, Yue
    Peng, Yun
    Qiu, Rong
    Xia, Kun
    Tang, Beisha
    Jiang, Hong
    EPIGENOMICS, 2019, 11 (09) : 1037 - 1055
  • [22] MOLECULAR AND CLINICAL CORRELATIONS IN SPINOCEREBELLAR ATAXIA TYPE-3 AND MACHADO-JOSEPH DISEASE
    MATILLA, T
    MCCALL, A
    SUBRAMONY, SH
    ZOGHBI, HY
    ANNALS OF NEUROLOGY, 1995, 38 (01) : 68 - 72
  • [23] Botulinum toxin type a for treatment of spasticity in spinocerebellar ataxia type 3 (Machado-Joseph disease)
    Freeman, W
    Wszolek, Z
    MOVEMENT DISORDERS, 2005, 20 (05) : 644 - 644
  • [24] Quality of Life since Pre-Ataxic Phases of Spinocerebellar Ataxia Type 3/Machado–Joseph Disease
    Gabriela Bolzan
    Vanessa Bielefeldt Leotti
    Camila Maria de Oliveira
    Gabriela Ecco
    Amanda Henz Cappelli
    Anastacia Guimarães Rocha
    Nathalia Kersting
    Mariana Rieck
    Lucas Schenatto de Sena
    Ana Carolina Martins
    Maria-Luiza Saraiva-Pereira
    Laura Bannach Jardim
    The Cerebellum, 2022, 21 : 297 - 305
  • [25] Spinocerebellar ataxia type 3 (Machado-Joseph disease):: severe destruction of the lateral reticular nucleus
    Rüb, U
    de Vos, RAI
    Schultz, C
    Brunt, ER
    Paulson, H
    Braak, H
    BRAIN, 2002, 125 : 2115 - 2124
  • [26] MRI T2-Relaxometry in Spinocerebellar Ataxia Type 3 (Machado-Joseph Disease)
    Silva, Beatriz
    Guimaraes, Rachel
    Bergo, Felipe
    Franca, Marcondes
    D'Abreu, Anelyssa
    Lopes-Cendes, Iscia
    Cendes, Fernando
    NEUROLOGY, 2012, 78
  • [27] MRI T2-relaxometry in spinocerebellar ataxia type 3 (Machado-Joseph disease)
    Silva, B. H. B.
    Guimaraes, R.
    Bergo, F.
    Franca, M. C., Jr.
    D'Abreu, A. C. F.
    Lopes-Cendes, I.
    Cendes, F.
    MOVEMENT DISORDERS, 2012, 27 : S232 - S232
  • [28] Spinocerebellar ataxia 3 and Machado-Joseph disease: Clinical, molecular, and neuropathological features
    Durr, A
    Stevanin, G
    Cancel, G
    Duyckaerts, C
    Abbas, N
    Didierjean, O
    Chneiweiss, H
    Benomar, A
    LyonCaen, O
    Julien, J
    Serdaru, M
    Penet, C
    Agid, Y
    Brice, A
    ANNALS OF NEUROLOGY, 1996, 39 (04) : 490 - 499
  • [29] Somatic mosaicism of the CAG repeat expansion in spinocerebellar ataxia type 3 Machado-Joseph disease
    Cancel, G
    Gourfinkel-An, I
    Stevanin, G
    Didierjean, O
    Abbas, N
    Hirsch, E
    Agid, Y
    Brice, A
    HUMAN MUTATION, 1998, 11 (01) : 23 - 27
  • [30] Vestibulo-ocular arreflexia in families with spinocerebellar ataxia type 3 (Machado-Joseph disease)
    Gordon, CR
    Joffe, V
    Vainstein, G
    Gadoth, N
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (10): : 1403 - 1406